LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10481-1 | Withaferin A | NSC 273757; NSC-101088 | LSM-6685 | 265237 | |
10132-1 | SNS-032 | BMS-387032 | LSM-1132 | 3025986 | |
10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 | 3062316 | |
10479-1 | Mitoxantrone | CL 232325; CL-232325; DHAQ; Novantron; Novantrone | LSM-2481 | 4212 | |
10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 | 42611257 | |
10084-1 | WZ3105 | LSM-5970 | 42628507 | ||
10157-1 | Foretinib | XL880; GSK1363089 | LSM-1158 | 42642645 | |
10059-1 | AZD-6482 | KIN001-193 | LSM-1059 | 44137675 | |
10009-1 | CP466722 | LSM-1009 | 44551660 | ||
10073-1 | PHA-793887 | LSM-1073 | 46191454 | ||
10086-1 | XMD11-50 | LRRK2-in-1 | LSM-1086 | 46843906 | |
10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 | 49830557 | |
10079-1 | Torin1 | LSM-1079 | 49836027 | ||
10052-1 | Sirolimus | Rapamycin | LSM-1052 | 5040 | |
10080-1 | Torin2 | LSM-1080 | 51358113 | ||
10011-1 | Alvocidib | Flavopiridol; HMR-1275; L868275 | LSM-1011 | 5287969 | |
10023-1 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 | 5291 | |
10148-1 | XL147 | SAR245408 | LSM-1149 | 52914932 | |
10117-1 | Celastrol | LSM-1117 | 5315765 | ||
10046-1 | SB590885 | LSM-42746 | 53239990 | ||
10071-1 | Palbociclib | PD0332991 | LSM-1071 | 5330286 | |
10119-1 | SU11274 | PKI-SU11274 | LSM-42791 | 53396327 | |
10018-1 | Neratinib | HKI-272 | LSM-42778 | 53398697 | |
10010-1 | CP724714 | LSM-42777 | 53401057 | ||
10161-1 | Luminespib | NVP-AUY922 | LSM-1162 | 53401173 |